Infertility is defined as inability to conceive naturally after one year of unprotected copulation. Within the field of reproductive state, infertility indicates a deficiency that does not compromise the physical ability of the individual, nor is it life-threatening. However, it could impact the development of individuals (both men and women), weaken their personality, and induce frustration. Around 50 million to 80 million couples suffer from infertility problems once in their reproductive lives. The situation of infertility is different in developing countries compared to developed countries. Apart from the endocrinological, anatomical, immunological, and genetic problems, a substantial percentage of women suffers from preventable problems such as pelvic inflammatory diseases (PIDs), postpartum infections, sexually transmitted infections, post?abortion infection, tubal damage, previous contraceptive complications, and polycystic ovary syndrome (PCOS).
The global infertility testing and treatment market can be segmented based on gender, end-user, and region. In terms of gender, the infertility testing and treatment market can be bifurcated into male infertility and female infertility. The male infertility segment can be classified into testing and treatment. The male infertility testing sub-segment can be categorized into oxidative stress analysis, computer-assisted semen analysis (CASA), microscopic examination, DNA fragmentation, sperm penetration assay, sperm agglutination, and others. The male infertility treatment sub-segment can be divided into sperm retrieval treatment, testicular sperm extraction (TESE), assisted reproductive techniques (ART), in vitro fertilization (IVF), vasectomy reversal, microsurgical sperm aspiration, varicocele repairs, intrauterine insemination (IUI), and intracytoplasmic sperm injection (ICSI). The female infertility segment can be bifurcated into testing and treatment. The female infertility testing sub-segment can be categorized into ovulation testing, laparoscopy, ovarian reserve testing, hysterosalpingography, transvaginal ultrasound, hormonal level testing, and others (genetic testing). The female infertility treatment sub-segment can be classified into in vitro fertilization (IVF), intrauterine insemination (IUI), and drug & hormone therapies.
Based on end-user, the global infertility testing and treatment market can be divided into hospitals, fertility & surgical centers, diagnostic centers, and others. The hospitals segment is projected to dominate the global infertility testing and treatment market during the forecast period. Better facilities provided by hospitals for infertility care is the key factor contributing to the high share of the segment. Increase in the number of fertility and surgical centers, and advanced quality of treatment provided by these settings are expected to propel the segment during the forecast period.
In terms of region, the global infertility testing and treatment market can be segmented into North America (U.S., and Canada), Europe (U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Mexico, Brazil, and Rest of Latin America), and Middle East & Africa (South Africa, Saudi Arabia, Israel, and Rest of Middle East and Africa). North America dominated the global infertility testing and treatment market in 2017 owing to rise in prevalence of infertility due to changing lifestyles. Europe was the second largest market for infertility testing and treatment in 2017 due to factors such as rise in expenditure in research.
Major players in the global infertility testing and treatment market are Illumina, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Delta Diagnostics, Quest Diagnostics Incorporated, Thermo Fisher Scientific, Inc., Vitrolife, FUJIFILM Irvine Scientific, Inc., Merck & Co., Inc., Genea Limited, and Ferring B.V.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.